Group 1 - The core viewpoint of the article is that Guohua Technology (000988.SZ) has been given a "buy" rating by Guojin Securities due to its potential for future performance growth despite a decline in revenue in Q3 [1] - The report highlights that the company's revenue has decreased both year-on-year and quarter-on-quarter, but the growth in contract liabilities lays a foundation for future performance expansion [1] - The company's profitability is steadily improving, supported by active investment in research and development [1] Group 2 - Guohua Technology is advancing its optical module business both domestically and internationally, with plans to consider a listing in Hong Kong [1] - The article also mentions the broader context of the Chinese innovative drug market, noting that overseas licensing has generated $80 billion this year, while the primary market is experiencing a fundraising slowdown [1]
国金证券给予华工科技“买入”评级,盈利能力稳步提升,拟筹划赴港上市